PMC's Annual Award for Leadership in Personalized Medicine
Ellen Sigal, Ph.D., Founder, Chairperson, Friends of Cancer Research, accepts the 14th Annual Award for Leadership in Personalized Medicine from Steven D. Averbuch, M.D., formerly Vice President and Head of Precision Medicine at Bristol-Myers Squibb.
2019 Winner to Be Announced in June
The Personalized Medicine Coalition (PMC) is no longer accepting nominations for the 15th Annual Award for Leadership in Personalized Medicine.
Thank you to all those who submitted a leader for consideration.
PMC will present the award to this year's winner, who will be named in June, during the 15th Annual Personalized Medicine Conference at Harvard Medical School, which will take place from November 13 - 14. The recipient will share his or her vision for the future of personalized medicine with conference attendees.
About the Award
The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.
PMC Board members are ineligible to receive the award.
Previous award recipients include:
- Ellen V. Sigal, Ph.D. (2018)
Friends of Cancer Research
- Jay T. Flatley (2017)
- Raju Kucherlapati, Ph.D. (2016)
Paul C. Cabot Professor of Genetics
Harvard Medical School
- Francis S. Collins, M.D., Ph.D. (2015)
National Institutes of Health (NIH)
- Mark Levin (2014)
Third Rock Ventures
- Kathy Giusti (2013)
Founder, Chief Executive Officer
Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
- Randal W. Scott, Ph.D. (2012)
- Leroy Hood, Ph.D., M.D. (2011)
Institute for Systems Biology
- William S. Dalton, Ph.D., M.D. (2010)
DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
- Brook Byers (2009)
Kleiner Perkins Caufield & Byers (KPCB)
- Michael O. Leavitt (2008)
Founder and Chairman
- Ralph Snyderman, M.D. (2007)
Founder and Chairman
- Elizabeth G. Nabel, M.D. (2006)
Brigham and Women's Health Care
- Janet Woodcock, M.D. (2005)
FDA Center for Drug Evaluation and Research